InnoCare Announces Approval of Clinical Trial of TYK2 Inhibitor ICP-332 in China
BEIJING--(BUSINESS WIRE)--InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced…
BEIJING--(BUSINESS WIRE)--InnoCare (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced…
SHANGHAI--(BUSINESS WIRE)--YouKuai Group International (“YouKuai” or the “Company”) today announces the completion of its $7.3…
Global beauty brand leverages pop culture to reframe mindsets on female stereotypes SHANGHAI, CHINA…
HONG KONG SAR - Media OutReach - 18 May 2021 - TECNO, a rising global…
SINGAPORE - Media OutReach - 18 May 2021 - As part of a concerted effort…
Study uncovers C-level attitudes on secure access as enterprises embrace the Everywhere Workplace SYDNEY--(BUSINESS WIRE)--Ivanti…
Global Net Sales +20% to US$807.0 Million for the Fourth Quarter Global Adjusted EBIT +43%…
Company received U.S. FDA clearance of Investigational New Drug Applications for four diverse pipeline candidates…
LONDON & PARIS & HOUSTON--(BUSINESS WIRE)--TechnipFMC (NYSE:FTI) (Paris:FTI) (ISIN:GB00BDSFG982) today announced that it has been…
Acquisition expands EverCommerce’s fitness and wellness solutions into new international markets DENVER--(BUSINESS WIRE)--EverCommerce, a leading…